The stock price of Gilead Sciences increased by 1.52%, indicating a positive movement. However, the fact that it lagged behind the broader market suggests that the increase may not be as significant in the context of overall market performance. This could lead to a neutral short-term impact as the rise is offset by the relative underperformance.